Penserra Capital Management’s Precision BioSciences DTIL Stock Holding History

Penserra Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,790	Closed	-$18K	–	1279
2023 Q3	$18K	Sell	1,790 -2,665	-60%	-$41K	﹤0.01%	1056
2023 Q2	$70K	Buy	4,455 +1,412	+46%	+$32.3K	﹤0.01%	1003
2023 Q1	$68K	Buy	3,043 +223	+8%	+$7.35K	﹤0.01%	819
2022 Q4	$100K	Sell	2,820 -453	-14%	-$17.9K	﹤0.01%	811
2022 Q3	$127K	Buy	3,273 +2,692	+463%	+$128K	﹤0.01%	707
2022 Q2	$27K	Buy	581 +59	+11%	+$3.46K	﹤0.01%	1051
2022 Q1	$48K	Buy	+522	New	+$70.9K	﹤0.01%	1007
2021 Q4	–	Sell	-45	Closed	-$15K	–	1416
2021 Q3	$15K	Buy	45 +1	+2%	+$339	﹤0.01%	1292
2021 Q2	$16K	Buy	44 +4	+10%	+$1.2K	﹤0.01%	1197
2021 Q1	$12K	Hold	40	–	–	﹤0.01%	1013
2020 Q4	$10K	Buy	40 +25	+167%	+$6.13K	﹤0.01%	924
2020 Q3	$2K	Buy	+15	New	+$2.98K	﹤0.01%	907

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Penserra Capital Management's DTIL Position: Q4 2023 in Review

Penserra Capital Management sold out of Precision BioSciences (DTIL) in Q4 2023, closing a stake of 1,790 shares — an estimated $18K sold.

Penserra Capital Management first reported a position in DTIL in Q3 2020 and held it in 12 quarters. The position peaked at $127K in Q3 2022. 65 funds tracked by Wall St. Rank hold DTIL as of Q4 2023.

Penserra Capital Management reported no remaining Precision BioSciences position as of Q4 2023 after selling out during the quarter.
Penserra Capital Management sold 1,790 Precision BioSciences shares in Q4 2023, an estimated $18K.
Penserra Capital Management first reported a position in Precision BioSciences in Q3 2020 and held it in 12 quarters.
Penserra Capital Management's Precision BioSciences position peaked at $127K in Q3 2022.
65 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2023.

Based on Penserra Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.